Exhibit
      31





Chief
      Executive and Financial Officer Certification (Section 302)





CERTIFICATION
      OF CHIEF EXECUTIVE AND FINANCIAL OFFICER


Pursuant
      to Section 302 of the Sarbanes-Oxley Act of 2002





I,
      Donald
      Perks, certify that:





(1)  I
      have reviewed this quarterly report on Form 10-QSB of Global Immune
      Technologies, Inc., ("Registrant").





(2)  Based
      on my knowledge, this quarterly report does not contain any untrue statement
      of
      a material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were
      made, not misleading with respect to the period covered by this quarterly
      report;





(3)  Based
      on my knowledge, the financial statements and other financial information
      included in this quarterly report, fairly present in all material respects
      the
      financial condition, results of operations and cash flows of the registrant
      as
      of, and for, the periods presented in this quarterly report;





(4)  The
      registrant's other certifying officers and I are
      responsible for establishing and maintaining disclosure controls and procedures
      (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant
      and have:





(a)  
      designed such disclosure controls and procedures, or caused such disclosure
      controls and procedures to be designed under our supervision, to ensure that
      material information relating to the registrant, including its consolidated
      subsidiaries, is made known to us by others within those entities, particularly
      during the period in which this quarterly report is being prepared;





(b)  
      evaluated the effectiveness of the registrant's
      disclosure controls and procedures and presented in this report our conclusions
      about the effectiveness of the disclosure controls and procedures, as of the
      end
      of the period covered by this report based on such evaluation; and





(c) 
      disclosed in this report any changes in the registrant’s internal control over
      financial reporting that occurred during the registrant’s most recent fiscal
      quarter (the registrant’s fourth fiscal quarter in the case of an quarterly
      report) that has materially affected, or is reasonably likely to materially
      affect, the registrant’s internal control over financial reporting;
      and





(5)   
      The registrant’s other certifying officers and I have disclosed, based on our
      most recent evaluation of the internal control over financial reporting, to
      the
      registrant's auditors and the audit committee of
      registrant’s board of directors (or persons performing the equivalent
      functions):





(a)  
      all significant deficiencies and material weaknesses in the design or operation
      of internal control over financial reporting which are reasonably likely to
      adversely affect the registrant's ability to
      record, process, summarize and report financial information ; and





(b)  
      any fraud, whether or not material, that involves management or other employees
      who have a significant role in the registrant's
      internal control over financial reporting.











Date:
                November 14, 2007By:
            /s/
                Donald PerksDonald
                PerksCEO,
                CFO